European Journal of Cardiovascular Medicine

This study scrutinizes the prevalence and demographic determinants of rhino-orbito-cerebral mucormycosis (ROCM) in the context of various factors including age, gender, and diabetic conditions, delineating clear patterns and potential risk factors that may contribute to the onset and exacerbation of ROCM. Methods This cross-sectional study was conducted to investigate the cerebrovascular involvements in patients diagnosed with COVID-19 associated mucormycosis (CAM) at hospitals affiliated with BMCRI. The study spanned from May 2021 to August 2021, during which time pertinent data from 49 patients were meticulously recorded and analyzed. Results The results underscored a significant gender disparity in ROCM prevalence, with males being more predominantly affected (p <0.05)[13]. Furthermore, the age group of 50-60 showed a heightened vulnerability to ROCM, especially amongst individuals with pre-existing diabetic conditions (p <0.001)[15,17,19]. Noteworthy was the exacerbation of symptoms and complications in patients with a history of steroid usage (p <0.01)[20]. A considerable portion of the cases also delineated a discernible difference in clinical outcomes between Mucor and Aspergillus infections in ROCM, paving the path for focused clinical strategies[21]. Conclusion: The study furnishes critical insights into the demographic precursors of ROCM, spotlighting age and diabetic conditions as potent risk factors. The findings beckon an immediate need to tailor medical interventions and community health programs that address these specific demographics, thereby potentially curtailing the incidence and severity of ROCM. Further research is advocated to establish a more intricate understanding of the disease dynamics.